United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4,010.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 110,977 shares of the company's stock after acquiring an additional 108,277 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's holdings in HCA Healthcare were worth $51,811,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. National Pension Service lifted its position in shares of HCA Healthcare by 2.9% during the 3rd quarter. National Pension Service now owns 626,585 shares of the company's stock valued at $267,051,000 after acquiring an additional 17,531 shares during the period. Nordea Investment Management AB raised its holdings in shares of HCA Healthcare by 11.2% during the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company's stock worth $507,393,000 after buying an additional 108,849 shares in the last quarter. Savant Capital LLC raised its holdings in shares of HCA Healthcare by 37.7% during the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company's stock worth $1,938,000 after buying an additional 1,246 shares in the last quarter. AlphaQuest LLC raised its holdings in shares of HCA Healthcare by 2,855.2% during the 3rd quarter. AlphaQuest LLC now owns 5,999 shares of the company's stock worth $2,557,000 after buying an additional 5,796 shares in the last quarter. Finally, Hudson Bay Capital Management LP raised its holdings in shares of HCA Healthcare by 154.5% during the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company's stock worth $2,000,000 after buying an additional 2,849 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.
HCA Healthcare Trading Down 2.1%
Shares of HCA stock opened at $384.01 on Friday. The stock has a market cap of $85.19 billion, a price-to-earnings ratio of 13.21, a PEG ratio of 1.24 and a beta of 1.18. The stock has a 50-day moving average of $454.43 and a 200-day moving average of $481.46. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company's quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio is presently 10.73%.
Analyst Ratings Changes
A number of equities analysts have recently commented on the company. Royal Bank Of Canada lowered their price target on HCA Healthcare from $593.00 to $534.00 and set an "outperform" rating for the company in a report on Monday, April 27th. Wells Fargo & Company lowered their price target on HCA Healthcare from $481.00 to $436.00 and set an "equal weight" rating for the company in a report on Monday, April 27th. TD Cowen lowered their target price on HCA Healthcare from $561.00 to $500.00 and set a "buy" rating for the company in a report on Monday, April 27th. KeyCorp lowered their target price on HCA Healthcare from $550.00 to $510.00 and set an "overweight" rating for the company in a report on Monday, April 27th. Finally, Barclays lowered their target price on HCA Healthcare from $551.00 to $496.00 and set an "overweight" rating for the company in a report on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $515.77.
View Our Latest Report on HCA
About HCA Healthcare
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.